[PDF][PDF] Construcción de un índice de privación para los barrios de Madrid y Barcelona

…, M Vicente Sánchez, B Alejos… - … Española de Salud …, 2013 - SciELO Public Health
Fundamentos: los indicadores socioeconómicos que toman el barrio como unidad de
referencia en nuestro contexto son escasos. Los objetivos de este artículo son describir el …

Dual therapy with darunavir and ritonavir plus lamivudine vs triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir …

…, P Barrufet, H Knobel, A Rivero, B Alejos… - Clinical Infectious …, 2017 - academic.oup.com
Background Our objective was to assess the therapeutic noninferiority of dual therapy with
darunavir/ritonavir and lamivudine compared to triple therapy with darunavir/ritonavir plus 2 …

HIV infection in migrant populations in the European Union and European Economic Area in 2007–2012: an epidemic on the move

V Hernando, D Alvárez-del Arco, B Alejos… - JAIDS Journal of …, 2015 - journals.lww.com
Background: Migrants are considered a key group at risk for HIV infection. This study describes
the epidemiology of HIV and the distribution of late HIV presentation among migrants …

Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial

…, J Rodríguez-Centeno, P Barruz, B Alejos… - The lancet HIV, 2021 - thelancet.com
Background DNA methylation-based estimators of biological age are reliable biomarkers of
the ageing process. We aimed to investigate a range of epigenetic ageing biomarkers in a …

[HTML][HTML] Impact of late presentation of HIV infection on short-, mid-and long-term mortality and causes of death in a multicenter national cohort: 2004–2013

…, J Gonzalez-Garcia, J Berenguer, P Sobrino, B Alejos… - Journal of Infection, 2016 - Elsevier
Objectives To analyze the impact of late presentation (LP) on overall mortality and causes of
death and describe LP trends and risk factors (2004–2013). Methods Cox models and …

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

…, MJ Vivancos, S Moreno, I Jarrin, B Alejos… - The lancet HIV, 2020 - thelancet.com
Background A low CD4/CD8 ratio during antiretroviral therapy (ART) identifies people with
heightened immunosenescence and increased risk of mortality. We aimed to assess the …

[HTML][HTML] Direct and indirect effectiveness of mRNA vaccination against severe acute respiratory syndrome coronavirus 2 in long-term care facilities, Spain

S Monge, C Olmedo, B Alejos, MF Lapeña… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We conducted a registries-based cohort study of long-term care facility residents> 65 years
of age offered vaccination against severe acute respiratory syndrome coronavirus 2 before …

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study

…, MÁ Muñoz‐Fernández, I Jarrin, B Alejos… - HIV …, 2021 - Wiley Online Library
Objectives We compared the characteristics and clinical outcomes of hospitalized individuals
with COVID‐19 with [people with HIV (PWH)] and without (non‐PWH) HIV co‐infection in …

La cohorte de la red española de investigación en sida y su biobanco: organización, principales resultados y pérdidas al seguimiento

…, P Labarga, F García, B Alejos-Ferreras… - … y Microbiología Clínica, 2011 - Elsevier
Introducción Este artículo describe el desarrollo de la cohorte de la Red Española de
Investigación en sida (CoRIS), sus aspectos metodológicos y organizativos, las características …

[HTML][HTML] Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non …

…, L Bermejo-Plaza, M Garcia-Alvarez, B Alejos… - …, 2020 - thelancet.com
Background We investigated the efficacy of a switch to dolutegravir plus lamivudine in aviremic
individuals without evidence of persistent lamivudine resistance-associated mutations in …